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Abstract
Background: The aim of this study was to investigate which surgical method is better in lymph node (LN)
dissection of lung cancer.
Methods: A comprehensive search of PubMed, Ovid MEDLINE, EMBASE, Web of Science, ScienceDirect, the
Cochrane Library, Scopus, and Google Scholar was performed to identify studies comparing thoracoscopic
lobectomy (video-assisted thoracic surgery (VATS) group) and thoracotomy (open group) in LN dissection.
Results: Twenty-nine articles met the inclusion criteria and involved 2763 patients in the VATS group and 3484
patients in the open group. The meta-analysis showed that fewer total LNs (95% confidence interval [CI] −1.52 to
−0.73, p < 0.0001) and N2 LNs (95% CI −1.25 to −0.10, p = 0.02) were dissected in the VATS group. A similar number
of total LN stations, N2 LN stations, and N1 LNs were harvested in both groups. Only one study reported that fewer
N1 LN stations were dissected in the VATS group (1.4 ± 0.5 vs. 1.6 ± 0.6, p = 0.04).
Conclusions: Open lobectomy could achieve better LN dissection efficacy than thoracoscopic lobectomy in the
treatment of lung cancer, especially in the N2 LNs dissection. These findings require validation by high-quality,
large-scale randomized controlled trials.
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Background
Lung cancer is the leading cause of cancer deaths in
many countries [1, 2]. Surgical treatment is the preferred
treatment for early-stage non-small cell lung cancer
(NSCLC). D’Cunha’s research showed that N1 and N2
lymph nodes (LNs) were positive in 27.5% of patients
with lung cancer under lobectomy [3]. However, non-
invasive examinations, such as computed tomography
(CT) and positron emission tomography-computed tom-
ography (PET-CT), are not sensitive and specific for the
clinical staging of lung cancer. Video-assisted thoracic
surgery (VATS) is the preferred surgical procedure, with
fewer incidences of postoperative complications and a
higher survival rate compared with thoracotomy [4–7].
However, whether VATS can achieve the same LN dis-
section efficacy is controversial, and there remains a lack
of high-quality, large-scale clinical research.
To determine whether VATS can achieve the same LN
dissection efficacy as thoracotomy in lung cancer, we
performed a systemic review and meta-analysis.
Methods
Search strategy
MEDLINE and manual searches were performed by two
investigators independently and in duplicate to identify
all relevant scientific articles published from January
1990 to May 2016. The MEDLINE search was
performed using PubMed, Ovid MEDLINE, EMBASE,
Web of Science, ScienceDirect, The Cochrane Library,
Scopus, and Google Scholar. The MeSH terms “lung
cancer or lung neoplasm”, “thoracotomy or open surgery”,
* Correspondence: yudongliang2015@163.com
Department of Cardiothoracic surgery, The second affiliated hospital of
Nanchang University, 1 Minde Rd, Nanchang, Jiangxi Province 330006, China
© The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Zhang et al. World Journal of Surgical Oncology  (2016) 14:290 
DOI 10.1186/s12957-016-1038-7
and “video-assisted thoracic surgery or VATS” and com-
parative study were used.
Inclusion criteria and exclusion criteria
The following inclusion criteria were applied: (1) pub-
lished in English, (2) compared the LN dissection of
thoracoscopic lobectomy with thoracotomy in treating
patients with lung cancer, and (3) the most recent study
was chosen when duplication of data is in more than
one article.
Reviews without original data, case reports, meta-
analyses, letters, expert opinions, and animal studies
were excluded. Studies on robotic-assisted VATS were
also excluded.
Data extraction
Two investigators independently extracted data from the
eligible studies. The extracted data included first author,
year of publication, geographical area, study design, dur-
ation of enrollment, information on preoperative staging,
number of patients per group, LN number (LNN), and
LN station number (LNS).
Quality assessment for included studies
Two investigators independently assessed the quality of
each included study using the Newcastle-Ottawa Scale
(NOS) for non-randomized studies and the Jadad scale
for randomized controlled trials (RCTs).
The NOS evaluates the quality of studies by analyzing
three items: selection, comparability, and exposure. The
scale assigns a maximum of nine points to each study: a
maximum of four points for selection, two points for
comparability, and three points for exposure. Therefore,
the highest quality study would score nine points. In our
analysis, high-quality studies were defined as those that
scored nine or eight points; medium-quality studies were
those that scored seven or six points [8].
The Jadad scale (five points) contained questions
for three main parts: randomization, masking, and ac-
countability of all patients (withdrawals and drop-
outs). Studies scored ≥3 points were considered as
high quality [9].
Statistical analysis
Meta-analysis was conducted by Review Manager 5.3
and SPSS 18.0, p value < 0.05 suggested statistically sig-
nificant. The differences were compared between the
two groups using analysis of variance for continuous
variables and pooled relative risk (RR) with 95% confi-
dence interval (CI) for categorical variables. We used
I2 and Cochran Q to evaluate the between-study het-
erogeneity. A random-effects model was adopted
when the heterogeneity was significant (p ≤ 0.10 and
I2 > 50%); otherwise, a fixed-effects model was used.
Rank correlation test of funnel plot asymmetry was
used to assess the potential publication bias.
Results
Search results and quality assessment of the included
studies
We initially identified 2341 publications from the
database and reference list searches and reviewed 29
articles for final analysis (Fig. 1). The articles involved
a total of 6247 patients, of whom 2763 underwent
VATS and 3484 underwent thoracotomy. Of these 29
publications, three studies were RCTs and 26 were
retrospective studies. According to the NOS and
Jadad scales assessment scores, 23 articles were of
good quality and the remaining six were medium
quality. The baseline characteristics of these articles
are listed in Table 1.
Comparison of total LNN and LNS
We identified 19 articles for total LNN comparison.
They involved 1297 patients in the VATS group and
1731 patients in the open group (thoracotomy). The
heterogeneity between these studies was acceptable
(p = 0.02, I2 = 44%). Fewer total LNs were dissected in
the VATS group as compared with the open group
(95% CI −1.52 to −0.73, p < 0.00001, Fig. 2a).
Fourteen articles were identified for total LNS
comparison. They involved 2046 patients in the VATS
group and 2373 patients in the open group. The mean
difference in total LNS between the two groups was not
significant (95% CI −0.28 to 0.06, p = 0.20), with signifi-
cant heterogeneity across studies (p < 0.00001, I2 = 73%,
Fig. 2b).
Comparison of N2 LNN and LNS
Eleven articles were identified for N2 LNN comparison.
They involved 726 patients in the VATS group and 1132
patients in the open group. The heterogeneity between
these studies was acceptable (p = 0.08, I2 = 41%). Fewer
N2 LNs were dissected in the VATS group as compared
with the open group (95% CI −1.38 to −0.49, p < 0.0001,
Fig. 3a).
Five articles were identified for N2 LNS comparison.
They involved 473 patients in the VATS group and
473 patients in the open group. The mean difference
in N2 LNS between the two groups was not signifi-
cant (95% CI −0.46 to 0.23, p = 0.50), with significant
heterogeneity across studies (p = 0.002, I2 = 76%, Fig. 3b).
Comparison of N1 LNN and LNS
Four articles were identified for N1 LNN comparison.
They involved 288 patients in the VATS group and 686
patients in the open group. The heterogeneity between
these studies was acceptable (p = 0.44, I2 = 60%). The
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mean difference in N1 LNN between the two groups
was not significant (95% CI −0.71 to 0.08, p = 0.11,
Fig. 4).
Only one article was identified for N1 LNS compari-
son. They involved 141 patients in the VATS group and
115 patients in the open group. The result showed that
fewer N1 LN stations were dissected in the VATS group
(1.4 ± 0.5 vs. 1.6 ± 0.6, p = 0.04).
Publication bias
The funnel plot for publication bias (standard error by
total LNN comparison) demonstrated marked evidence
of symmetry (Fig. 5), indicating no publication bias. The
combined effect size yielded a Z value of 5.64, with a
corresponding p < 0.00001. This result indicates that the
fail-safe N value was relevant.
Discussion
The presence or absence of mediastinal LN metasta-
ses is a critical component to accurate staging and
therefore a key component of the surgical manage-
ment of NSCLC [10]. Both overall and disease-free
survival have been associated with the number of LNs
dissected [11, 12]. Lardinois compared LNs dissection
versus sampling; the results showed a longer disease-
free survival and better local tumor control in dissec-
tion groups [13]. Focusing on stage IA lung cancer,
Xu reported a similar result and suggested that the
number of N2 stations served as a more significant
prognostic factor [14]. As a result, current guidelines
from the National Comprehensive Cancer Network
and European Society of Thoracic Surgeons recom-
mend that all patients with resectable NSCLC should
have a complete systematic nodal dissection, with at
least three N2 stations dissected [15, 16].
Although VATS is associated with many benefits in
comparison to thoracotomy, whether VATS can
achieve the same LN dissection efficacy in patients
with lung cancer remains controversial [7, 17, 18].
Flores reported that the surgical field in VATS facili-
tated the dissection of LNs adjacent to the blood ves-
sels and the trachea and found that smaller nodes
achieved better LN dissection [19]. Ramos showed that
VATS dissected more total LNS (5.1 ± 1.1 vs. 4.5 ± 1.2,
p < 0.001) and mediastinal LNS (3.4 ± 0.9 vs. 3.2 ± 0.9,
p = 0.022) when compared with thoracotomy [20]. By
contrast, Denlinger reported that significantly more
overall LNs were dissected in the open group than in
the VATS group (8.9 ± 5.2 vs. 7.1 ± 5.2, p = 0.0006)
[21]. Similar results were reported by Lee and col-
leagues in their retrospective study of LN evaluation
achieved by VATS lobectomy compared with that by
open lobectomy [22]. A secondary analysis including
752 original participants of the American College of
Fig. 1 Flow diagram of screened and included papers
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Table 1 Summary of the 29 trials included in the present meta-analysis
Study Institution Enrolled year No. of patients Clinical stage Outcomes Design Quality
VATS Open VATS Open
1995 Kirby [28] USA Single 1991.10–1993.12 1991.10–1993.12 25 30 I ① RCT 3
1998 Morikawa [29] JPN Single 1996.04–1996.12 1995.01–1996.03 39 41 I–II ③ Retrospective 9
2000 Luketich [30] USA Single Not mentioned Not mentioned 31 31 I ① Retrospective 7
2000 Sugi [31] JPN Single 1993.01–1994.06 1993.01–1994.06 48 52 Ia ③, ⑤ RCT 3
2001 Nomori [32] JPN Single 1999.08–2000.12 1998.04–1999.07 33 33 I ①,⑦,⑧ Retrospective 7
2005 Watanabe [33] JPN Single 1997–2004 1997–2004 221 190 I ①, ③, ⑦, ⑧ Retrospective 8
2006 Petersen [34] USA Single 2001–2005 1996–2005 12 85 I–IV ② Retrospective 8
2006 Shigemura [35] JPN Multi 1999.01–2004.01 1999.01–2004.01 50 55 Ia ① Retrospective 9
2008 Shiraishi [36] JPN Single 1994.11–2005.10 1994.11–2005.10 20 55 I ③, ⑤ Retrospective 8
2008 Watanabe [37] JPN Single 1997–2006 1997–2006 37 32 I ①, ②, ③, ④ Retrospective 8
2008 Whitson [38] USA Single Not mentioned Not mentioned 6 7 Not mentioned ① Retrospective 6
2009 Nakanishi [39] JPN Single 2000.04–2007.01 2000.04–2007.01 13 14 I–IV ③ Retrospective 8
2009 Okur [40] TR Single 2007.01–2007.11 2007.01–2007.11 20 28 I ② Retrospective 8
2010 Denlinger [21] USA Single 2000.01–2008.08 2000.01–2008.08 79 464 I ①, ③, ⑤ Retrospective 8
2011 D’Amico [41] USA Single 2007.01–2010.09 2007.01–2010.09 199 189 I–III ②,④ Retrospective 7
2012 Bu [42] CHN Single 2001.05–2011.04 2001.05–2011.04 46 87 Not mentioned ①, ② Retrospective 7
2012 Li [43] CHN Single 2006.09–2009.12 2006.09–2009.12 29 47 I ③, ④ Retrospective 8
2012 Licht [44] DNK Multi 2007.01–2011.12 2007.01–2011.12 717 796 I ② Retrospective 8
2013 Fan [45] CHN Single 2005.01–2010.12 2005.01–2010.12 79 77 I–II ①, ② Retrospective 8
2013 Lee [22] USA Single 1990.05–2011.12 1990.05–2011.12 141 115 Not mentioned ①, ②, ③, ④, ⑤, ⑥ Retrospective 8
2013 Palade [46] GER Single 2008.05–2011.12 2008.05–2011.12 32 32 I ①, ⑦, ⑧ RCT 3
2013 Zhong [47] CHN Single 2006.03–2011.08 2006.03–2011.08 67 90 I ①, ②, ③, ④ Retrospective 8
2014 Li [48] CHN Single 2011.02–2013.02 2011.02–2013.02 21 32 I–II ① Retrospective 8
2014 Stephens [4] USA Single 2002.01–2011.12 2002.01–2011.12 307 307 I ② Retrospective 8
2015 Cai [49] CHN Single 2010.01–2012.05 2010.01–2012.05 71 67 I–II ①, ② Retrospective 9
2015 Kuritzky [50] USA Single 2007–2012 2007–2012 74 224 I ② Retrospective 8
2015 Murakawa [51] JPN Single 2001–2010 2001–2010 101 101 I ①, ② Retrospective 8
2015 Nwogu [6] USA Multi 2004.10–2010.06 2004.10–2010.06 175 175 I–II ①, ② Retrospective 7
2015 Zhang [52] CHN Single 2012.10–2013.11 2012.10–2013.11 70 28 I ① Retrospective 9
① total lymph node number, ② total lymph node station number, ③ N2 LNN, ④ N2 LNS, ⑤ N1 LNN, ⑥ N1 LNS, ⑦ left-side LNN, ⑧ right-side LNN













Surgeons Oncology Group Z0030 trial compared pa-
tients who underwent lobectomy by VATS with pa-
tients who underwent thoracotomy. The results
showed that there was no significant difference in the
overall number of LNs retrieved between the two
groups (15 vs. 19, p = 0.147) [23].
The present study included a total of 7568 patients
from nine countries, providing the most comprehen-
sive evidence for LN dissection efficacy by VATS to
date. The meta-analysis showed that fewer total LNN
and similar total LNS were dissected in the VATS
group as compared with that in the open group. If
we only included studies focusing on clinical stage I
lung cancer, the results were similar (total LNN, 95%
CI −1.67 to −0.61, p < 0.0001; total LNS, 95% CI
−0.62 to 0.02, p = 0.07). It suggests that surgeons may
not have the ability to perform systematic lymphade-
nectomy in VATS or ignore the importance of sys-
tematic lymphadenectomy for various reasons (earlier
tumor stage, worrying about damage to vital organs,
and so on).
In the comparison of N1 and N2 LN dissection, our
results showed that similar number of N1 LNN and
N2 LNS could be harvested by VATS, while fewer N2
LNN were harvested by VATS as compared with
thoracotomy. Only one article reported on N1 LNS
comparison between the two groups and showed bet-
ter efficiency in the open group (1.4 ± 0.5 vs. 1.6 ± 0.6,
p = 0.04) [22].
It was controversial that removing more N2 LNs
could increase the accuracy of clinical staging of
NSCLC. Boffa et al. compared the completeness of
surgical LN evaluation during anatomic resection of
primary lung cancer by open and VATS approaches
in 11,531 patients from The Society of Thoracic
Surgeons-General Thoracic Database. The results
showed nodal upstaging in 14.3% (1024 patients) of
the open group and in 11.6% (508 patients) of the
VATS group (p < 0.001). The study suggested that sur-
geons should be encouraged to apply a systematic ap-
proach to hilar and peribronchial LN dissection
during VATS lobectomy for lung cancer, particularly
as they were adopting this approach [24].
Some surgeons might also worry about the compli-
cations caused by the systematic LN dissection. As
with open thoracotomy, systematic mediastinal LN
Fig. 2 Forest plot of the mean difference in total LNN (a) and LNS (b) in the VATS group vs. the open group
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dissection under VATS may increase the risk of in-
traoperative bleeding (bronchial arteries, etc.), tra-
cheobronchial injury, recurrent nerve injury, prolonged
air leak, atrial fibrillation, and pulmonary edema
[25]. In other papers, Watanabe et al. reported simi-
lar mortality and morbidity of mediastinal LN dissec-
tion by VATS vs. open lobectomy, indicating that
systematic mediastinal LN dissection by VATS is a
safe procedure [26]. Zhang et al. compared compli-
cations such as chylothorax and nerve injury be-
tween VATS and open thoracotomy in a meta-
analysis. The results showed that these events were
similar in both groups [27].
The possible limitations of our study must be consid-
ered when interpreting the findings described herein.
First, including only English papers might have resulted
in language bias. Second, including 7568 participants
from 36 studies with only three RCTs might have weak-
ened the quality of the results. Third, the number of dis-
sected LNs varied significantly between the included
studies. Different doctors have different understanding
of LN dissection and might be at different stages of the
learning curve. Some data did not meet the National
Comprehensive Cancer Network guide requirements for
lung cancer surgery treatment of systematic LN dis-
section, which may have affected the reliability of the
Fig. 3 Forest plot of the mean difference in N2 LNN (a) and LNS (b) in the VATS group vs. the open group
Fig. 4 Forest plot of the mean difference in N1 LNN in the VATS group vs. the open group
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results. Fourth, there is great potential for LN frag-
mentation during dissection. Different pathologists
and different counting procedures might lead to false
LNN counts, which might increase the heterogeneity
between studies but would not alter the overall re-
sults. Finally, we did not analyze the survival differ-
ence between VATS and open thoracotomy. Our
analysis compared LN harvest capability between two
evaluation procedures only from a surgical point of
view and tried to give further proof of satisfied onco-
logic efficacy by VATS.
Conclusions
Less total and mediastinal LNs were evaluated with
VATS than with thoracotomy in the present study. Both
approaches harvested a similar number of total LN sta-
tions, mediastinal LN stations, and N1 LNs. However,
owing to the possible existing bias in the original studies,
inter-study heterogeneity, and the inherent limitations of
our meta-analysis, the findings require validation in
high-quality, large-scale RCTs.
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